approval
saveTRILEPTAL (OXCARBAZEPINE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalOXCARBAZEPINE — FDA approvalMar 2, 2026 · 216d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 23, 2025 · 376d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 23, 2025 · 376d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 4, 2024 · 760d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 4, 2024 · 760d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalJan 4, 2019 · 2830d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalJan 4, 2019 · 2830d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalMar 22, 2018 · 3118d ago
same company · ±60 days · 6
- approvalImatinib Mesylate Shilpa: GLEEVEC (IMATINIB MESYLATE) — FDA approvalApr 18, 2003
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalFeb 14, 2003
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalFeb 14, 2003
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalFeb 14, 2003
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalFeb 14, 2003
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalFeb 14, 2003
comments(0)
5-min edit window · permanent after that